Cara Therapeutics | CARA - Собственный капитал и резервы





Собственный капитал и резервы Изменить Дата
Acadia Pharmaceuticals USD 917.27M 94.89M 2025-09
Alterity Therapeutics Limited AUD 36.21M 18.58M 2025-12
Assertio Holdings USD 105.8M 12.5M 2025-09
Cara Therapeutics USD 27.87M 5.06M 2025-09
Cassava Sciences USD 74.4M 7.16M 2025-12
Chugai Pharma JPY 2.03T 135.62B 2025-12
Cipla INR 329.19B 16.3B 2025-09
Clal Biotechnology ILS 121.41M 4.62M 2023-12
Compugen USD 102.73M 58.9M 2025-12
CSL USD 18.66B 2.75B 2025-12
Grifols EUR 6.21B 133.12M 2025-12
Halozyme Therapeutics USD 48.81M 455.1M 2025-12
J&J USD 81.19B 358M 2026-03
Neurocrine Biosciences USD 3.41B 154.3M 2026-03
Pacira USD 653.89M 39.22M 2026-03
Pfizer USD 90.1B 3.63B 2026-03
RedHill Biopharma USD -4.41M 271K 2025-06
Supernus Pharmaceuticals USD 1.08B 15.09M 2026-03
Vanda Pharmaceuticals USD 327.19M 138.81M 2025-12